Generali Asset Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.1M Buy
115,587
+6,411
+6% +$1.95M 0.91% 24
2026
Q1
$23.3M Sell
109,176
-6,236
-5% -$1.39M 0.49% 41
2025
Q4
$19.8M Sell
115,412
-15,309
-12% -$2.38M 0.4% 49
2025
Q3
$17.5M Buy
130,721
+16,352
+14% +$1.73M 0.37% 60
2025
Q2
$11.1M Sell
114,369
-48,135
-30% -$3.82M 0.25% 85
2025
Q1
$11.8M Sell
162,504
-892
-0.5% -$70.2K 0.29% 78
2024
Q4
$11.8M Buy
+163,396
New +$12.4M 0.3% 68

Other funds holding LRCX

Generali Asset Management's LRCX Position: Q2 2026 in Review

Generali Asset Management increased its Lam Research (LRCX) stake by 5.9% in Q2 2026, buying an estimated $1.95M and bringing the position to 115,587 shares worth $50.1M. The position accounts for 0.91% of the portfolio, ranked #24.

Generali Asset Management first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Generali Asset Management held 115,587 shares of Lam Research worth $50.1M as of Q2 2026.
  • Generali Asset Management bought 6,411 Lam Research shares in Q2 2026, an estimated $1.95M.
  • Lam Research made up 0.91% of Generali Asset Management's portfolio in Q2 2026, its #24 holding.
  • Generali Asset Management first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.